Price
Financials
Standalone, Rs crore| Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.20 | 0.09 | 0.20 | 0.00 | 0.07 | 0.17 | 0.40 | 0.00 | 0.15 | 0.17 | 0.16 | 0.20 |
| Expenses | 0.20 | 0.09 | 0.20 | 0.00 | 0.07 | 0.17 | 0.40 | 0.01 | 0.16 | 0.19 | 0.16 | 0.20 |
| Operating Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | -0.02 | 0.00 | 0.00 |
| OPM % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -6.67% | -11.76% | 0.00% | 0.00% | ||
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Tax % | 0.00% | |||||||||||
| Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS in Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 |
| Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.22 | 0.28 | 0.30 | 0.32 | 0.03 | 0.03 | 0.49 | 0.44 | 0.75 | 0.68 |
| Expenses | 0.19 | 0.29 | 0.26 | 0.32 | 0.03 | 0.03 | 0.49 | 0.44 | 0.75 | 0.71 |
| Operating Profit | 0.03 | -0.01 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.03 |
| OPM % | 13.64% | -3.57% | 13.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -4.41% |
| Other Income | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.02 | 0.01 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Tax % | 50.00% | 0.00% | 0.00% | |||||||
| Net Profit | 0.01 | 0.01 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS in Rs | 0.02 | 0.02 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 19% | 192% | 6% | ||
| Compounded Profit Growth | % | % | % | % | ||
| Stock Price CAGR | 8% | % | % | % | ||
| Return on Equity | % | 0% | 0% | 0% |
| Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.10 | 4.10 | 4.10 | 4.10 | 4.10 | 4.10 | 4.10 | 4.10 | 4.10 |
| Reserves | 0.20 | 0.21 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 |
| Borrowings | 0.35 | 0.34 | 0.34 | 0.34 | 0.34 | 0.23 | 0.40 | 0.45 | 0.45 |
| Other Liabilities | 0.01 | 0.01 | 0.03 | 0.01 | 0.01 | 0.01 | 0.49 | 0.89 | 1.00 |
| Total Liabilities | 4.66 | 4.66 | 4.70 | 4.68 | 4.68 | 4.57 | 5.22 | 5.67 | 5.78 |
| Fixed Assets | 0.22 | 0.21 | 0.20 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 4.44 | 4.45 | 4.50 | 4.48 | 4.68 | 4.57 | 5.22 | 5.67 | 5.78 |
| Total Assets | 4.66 | 4.66 | 4.70 | 4.68 | 4.68 | 4.57 | 5.22 | 5.67 | 5.78 |
| Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 0.03 | -0.01 | 0.04 | 0.00 | 0.00 | 0.01 | 0.05 | 0.00 | 0.04 |
| Cash from Investing Activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash Flow | 0.03 | -0.01 | 0.04 | 0.00 | 0.00 | 0.01 | 0.05 | 0.00 | 0.04 |
| Free Cash Flow | 0.03 | -0.01 | 0.04 | 0.00 | 0.00 | 0.01 | 0.05 | 0.00 | 0.04 |
| CFO/OP | 100% | 100% | 100% |
| Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 39.11 | 36.50 | 34.22 | 365.00 | 0.00 | 365.00 | 763.18 | 408.80 |
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Days Payable | |||||||||
| Cash Conversion Cycle | 0.00 | 39.11 | 36.50 | 34.22 | 365.00 | 0.00 | 365.00 | 763.18 | 408.80 |
| Working Capital Days | 6,752.50 | 26.07 | 24.33 | 34.22 | 365.00 | 0.00 | -119.18 | -149.32 | -175.20 |
| ROCE % | 0.22% | 0.64% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 8.98% | 8.98% | 8.98% | 8.98% | 8.98% | 8.98% | 8.98% | 8.98% | 8.98% | 8.98% | 8.98% |
| Public | 91.02% | 91.02% | 91.02% | 91.02% | 91.02% | 91.02% | 91.02% | 91.02% | 91.02% | 91.02% | 91.02% |
| No. of Shareholders | 7,609 | 7,609 | 7,609 | 7,609 | 7,609 | 7,609 | 7,609 | 7,609 | 7,609 | 7,609 | 7,609 |
Fundamentals
Market Cap₹ 1.73 Cr.
Current Price₹ 4.20
Book Value₹ 10.6
ROCE0.00 %
ROE0.00 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)6%
Compounded Profit Growth (TTM)%
Standalone figures.
Valuation
P/B, 3-year average0.35x
P/B, 5-year average0.87x
Profitability
Operating margin (excl. other income)0.00%
Operating margin (incl. other income)0.00%
Growth
Sales growth (latest year)-10.20%
Sales CAGR, 3 years144.78%
Sales CAGR, 5 years7.96%
Sales growth QoQ25.00%
Per share
Book value per shareRs 10.54
Sales per shareRs 1.65
Free cash flow per shareRs 0.10
Efficiency
Asset turnover0.08x
Debtor days763 days
Debtors turnover0.48x
Cash conversion cycle409 days
Working capital days-175 days
Leverage
Total debtRs 0 Cr
Cash and bankRs 0 Cr
Net debtRs 0 Cr
Debt to equity0.10x
Owners' fund to total sources76.37%
Debt to assets7.94%
Cash flow
Free cash flow (latest year)Rs 0 Cr
FCFE (approx.: FCF + change in debt)Rs 0 Cr
Statement figures
Net sales (TTM)Rs 1 Cr
Net sales (latest year)Rs 0 Cr
Sales (latest quarter)Rs 0 Cr
Operating profit excl. other income (latest year)Rs 0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total expenditure (latest year)Rs 0 Cr
Total income (latest year)Rs 0 Cr
Share capitalRs 4 Cr
ReservesRs 0 Cr
Shareholders' fundsRs 4 Cr
Total assetsRs 6 Cr
ReceivablesRs 1 Cr
Other liabilitiesRs 1 Cr
Shares outstanding (crore)0.41
Ownership
Promoter holding8.98% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 57.5 is at the 76th percentile of its own 2.1-year range
(median 56.2, low 33.8, high 62.9).
P/B 0.40 is at the 76th percentile (median 0.39).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Not enough price history.
Red flags
F-score 8 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Sep 2018Sales ₹0 Cr.
Net profit ₹0 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Poly Medicure Ltd | 16,671 | 52.1 | 12.5 % |
| Molbio Diagnostics Ltd | 14,470 | 66.6 | 18.0 % |
| Fischer Medical Ventures Ltd | 2,355 | 96.2 | 11.4 % |
| Tarsons Products Ltd | 1,754 | 148 | 4.59 % |
| Q-Line Biotech Ltd | 1,569 | 27.8 | 22.5 % |
| Laxmi Dental Ltd | 1,058 | 30.4 | 15.0 % |
| Hemant Surgical Industries Ltd | 869 | 51.3 | 18.9 % |
| Vasa Denticity Ltd | 754 | 62.3 | 7.54 % |
| OSEL Devices Ltd | 691 | 23.6 | 24.4 % |
| Prevest Denpro Ltd | 462 | 20.5 | 24.9 % |
| QMS Medical Allied Services Ltd | 419 | 39.0 | 12.9 % |
| Nureca Ltd | 349 | 80.4 | 3.30 % |
| Aprameya Engineering Ltd | 200 | 39.7 | 12.6 % |
| Avience Biomedicals Ltd | 198 | 22.7 | 27.0 % |
| Earkart Limited | 179 | 36.3 | 17.5 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Gujarat Meditech Ltd?
Gujarat Meditech Ltd (524754) has a market capitalisation of Rs 1.73 Cr. at the close.
What were Gujarat Meditech Ltd's latest quarterly results?
In the Sep 2018 quarter, Gujarat Meditech Ltd sales was Rs 0 Cr and net profit was Rs 0 Cr.